Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)John D. Hainsworth, David R. Spigel, Fred J. Kudrik et al.|Lung Cancer|2018Cited by 12
Trilaciclib (G1T28): A cyclin dependent kinase 4/6 inhibitor, in combination with etoposide and carboplatin (EP) for extensive stage small cell lung cancer (ES-SCLC)—Phase 1b results.Caio Max S. Rocha Lima, Taofeek K. Owonikoko, Patrick J. Roberts et al.|Journal of Clinical Oncology|2017Cited by 9
A Phase II Trial of Combined Bendamustine, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma (MM) Patients Who Are Not Candidates for High-Dose Chemotherapy: Results of a Planned Interim Safety AnalysisJesús G. Berdeja, Ian W. Flinn, Ines Macias‐Perez et al.|Blood|2011Cited by 2